Taylor Morrison Home Corporation
Taylor Morrison Home Corporation (TMHC) Stock Competitors & Peer Comparison
See (TMHC) competitors and their performances in Stock Market.
Peer Comparison Table: Residential Construction Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TMHC | $63.24 | -1.69% | 5.9B | 9.42 | $6.71 | N/A |
| DHI | $159.90 | -2.63% | 46.3B | 15.00 | $10.66 | +1.05% |
| PHM | $127.56 | -2.36% | 24.5B | 11.47 | $11.12 | +0.75% |
| LEN | $94.05 | -0.14% | 23.8B | 13.53 | $6.95 | +2.12% |
| LEN-B | $91.50 | -0.69% | 23.2B | 13.17 | $6.95 | +2.12% |
| NVR | $6,503.95 | -2.48% | 18.1B | 15.89 | $409.48 | N/A |
| TOL | $146.64 | -1.75% | 13.9B | 10.53 | $13.93 | +0.68% |
| IBP | $302.57 | -2.07% | 8.2B | 31.19 | $9.70 | +1.09% |
| MDC | $62.98 | +0.05% | 4.7B | 11.91 | $5.29 | +3.41% |
| MTH | $69.07 | -1.19% | 4.6B | 12.60 | $5.48 | +2.53% |
Stock Comparison
TMHC vs DHI Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, DHI has a market cap of 46.3B. Regarding current trading prices, TMHC is priced at $63.24, while DHI trades at $159.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas DHI's P/E ratio is 15.00. In terms of profitability, TMHC's ROE is +0.11%, compared to DHI's ROE of +0.13%. Regarding short-term risk, TMHC is less volatile compared to DHI. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check DHI's competition here
TMHC vs PHM Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, PHM has a market cap of 24.5B. Regarding current trading prices, TMHC is priced at $63.24, while PHM trades at $127.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas PHM's P/E ratio is 11.47. In terms of profitability, TMHC's ROE is +0.11%, compared to PHM's ROE of +0.16%. Regarding short-term risk, TMHC is less volatile compared to PHM. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check PHM's competition here
TMHC vs LEN Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, LEN has a market cap of 23.8B. Regarding current trading prices, TMHC is priced at $63.24, while LEN trades at $94.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas LEN's P/E ratio is 13.53. In terms of profitability, TMHC's ROE is +0.11%, compared to LEN's ROE of +0.08%. Regarding short-term risk, TMHC is less volatile compared to LEN. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LEN's competition here
TMHC vs LEN-B Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, LEN-B has a market cap of 23.2B. Regarding current trading prices, TMHC is priced at $63.24, while LEN-B trades at $91.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas LEN-B's P/E ratio is 13.17. In terms of profitability, TMHC's ROE is +0.11%, compared to LEN-B's ROE of +0.08%. Regarding short-term risk, TMHC is more volatile compared to LEN-B. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check LEN-B's competition here
TMHC vs NVR Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, NVR has a market cap of 18.1B. Regarding current trading prices, TMHC is priced at $63.24, while NVR trades at $6,503.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas NVR's P/E ratio is 15.89. In terms of profitability, TMHC's ROE is +0.11%, compared to NVR's ROE of +0.33%. Regarding short-term risk, TMHC is less volatile compared to NVR. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check NVR's competition here
TMHC vs TOL Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, TOL has a market cap of 13.9B. Regarding current trading prices, TMHC is priced at $63.24, while TOL trades at $146.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas TOL's P/E ratio is 10.53. In terms of profitability, TMHC's ROE is +0.11%, compared to TOL's ROE of +0.17%. Regarding short-term risk, TMHC is less volatile compared to TOL. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check TOL's competition here
TMHC vs IBP Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, IBP has a market cap of 8.2B. Regarding current trading prices, TMHC is priced at $63.24, while IBP trades at $302.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas IBP's P/E ratio is 31.19. In terms of profitability, TMHC's ROE is +0.11%, compared to IBP's ROE of +0.39%. Regarding short-term risk, TMHC is less volatile compared to IBP. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check IBP's competition here
TMHC vs MDC Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, MDC has a market cap of 4.7B. Regarding current trading prices, TMHC is priced at $63.24, while MDC trades at $62.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas MDC's P/E ratio is 11.91. In terms of profitability, TMHC's ROE is +0.11%, compared to MDC's ROE of +0.04%. Regarding short-term risk, TMHC is more volatile compared to MDC. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check MDC's competition here
TMHC vs MTH Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, MTH has a market cap of 4.6B. Regarding current trading prices, TMHC is priced at $63.24, while MTH trades at $69.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas MTH's P/E ratio is 12.60. In terms of profitability, TMHC's ROE is +0.11%, compared to MTH's ROE of +0.07%. Regarding short-term risk, TMHC is more volatile compared to MTH. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check MTH's competition here
TMHC vs SKY Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, SKY has a market cap of 4.6B. Regarding current trading prices, TMHC is priced at $63.24, while SKY trades at $82.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas SKY's P/E ratio is 21.88. In terms of profitability, TMHC's ROE is +0.11%, compared to SKY's ROE of +0.14%. Regarding short-term risk, TMHC is more volatile compared to SKY. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check SKY's competition here
TMHC vs CVCO Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, CVCO has a market cap of 4.2B. Regarding current trading prices, TMHC is priced at $63.24, while CVCO trades at $539.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas CVCO's P/E ratio is 23.43. In terms of profitability, TMHC's ROE is +0.11%, compared to CVCO's ROE of +0.17%. Regarding short-term risk, TMHC is more volatile compared to CVCO. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check CVCO's competition here
TMHC vs TPH Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, TPH has a market cap of 4B. Regarding current trading prices, TMHC is priced at $63.24, while TPH trades at $46.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas TPH's P/E ratio is 17.24. In terms of profitability, TMHC's ROE is +0.11%, compared to TPH's ROE of +0.07%. Regarding short-term risk, TMHC is more volatile compared to TPH. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check TPH's competition here
TMHC vs KBH Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, KBH has a market cap of 3.5B. Regarding current trading prices, TMHC is priced at $63.24, while KBH trades at $55.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas KBH's P/E ratio is 10.67. In terms of profitability, TMHC's ROE is +0.11%, compared to KBH's ROE of +0.09%. Regarding short-term risk, TMHC is less volatile compared to KBH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check KBH's competition here
TMHC vs MHO Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, MHO has a market cap of 3.4B. Regarding current trading prices, TMHC is priced at $63.24, while MHO trades at $133.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas MHO's P/E ratio is 9.06. In terms of profitability, TMHC's ROE is +0.11%, compared to MHO's ROE of +0.10%. Regarding short-term risk, TMHC is less volatile compared to MHO. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check MHO's competition here
TMHC vs GRBK Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, GRBK has a market cap of 3.1B. Regarding current trading prices, TMHC is priced at $63.24, while GRBK trades at $70.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas GRBK's P/E ratio is 10.02. In terms of profitability, TMHC's ROE is +0.11%, compared to GRBK's ROE of +0.18%. Regarding short-term risk, TMHC is more volatile compared to GRBK. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check GRBK's competition here
TMHC vs HOVNP Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, HOVNP has a market cap of 3.1B. Regarding current trading prices, TMHC is priced at $63.24, while HOVNP trades at $20.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas HOVNP's P/E ratio is -8.42. In terms of profitability, TMHC's ROE is +0.11%, compared to HOVNP's ROE of +0.07%. Regarding short-term risk, TMHC is less volatile compared to HOVNP. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check HOVNP's competition here
TMHC vs CCS Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, CCS has a market cap of 1.7B. Regarding current trading prices, TMHC is priced at $63.24, while CCS trades at $59.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas CCS's P/E ratio is 13.47. In terms of profitability, TMHC's ROE is +0.11%, compared to CCS's ROE of +0.05%. Regarding short-term risk, TMHC is less volatile compared to CCS. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check CCS's competition here
TMHC vs DFH Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, DFH has a market cap of 1.4B. Regarding current trading prices, TMHC is priced at $63.24, while DFH trades at $15.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas DFH's P/E ratio is 7.10. In terms of profitability, TMHC's ROE is +0.11%, compared to DFH's ROE of +0.14%. Regarding short-term risk, TMHC is less volatile compared to DFH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check DFH's competition here
TMHC vs LGIH Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, LGIH has a market cap of 1.1B. Regarding current trading prices, TMHC is priced at $63.24, while LGIH trades at $45.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas LGIH's P/E ratio is 14.58. In terms of profitability, TMHC's ROE is +0.11%, compared to LGIH's ROE of +0.04%. Regarding short-term risk, TMHC is less volatile compared to LGIH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LGIH's competition here
TMHC vs GRBK-PA Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, GRBK-PA has a market cap of 1B. Regarding current trading prices, TMHC is priced at $63.24, while GRBK-PA trades at $23.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas GRBK-PA's P/E ratio is 5.24. In terms of profitability, TMHC's ROE is +0.11%, compared to GRBK-PA's ROE of +0.18%. Regarding short-term risk, TMHC is more volatile compared to GRBK-PA. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check GRBK-PA's competition here
TMHC vs BZH Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, BZH has a market cap of 662.5M. Regarding current trading prices, TMHC is priced at $63.24, while BZH trades at $22.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas BZH's P/E ratio is 77.41. In terms of profitability, TMHC's ROE is +0.11%, compared to BZH's ROE of +0.01%. Regarding short-term risk, TMHC is less volatile compared to BZH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check BZH's competition here
TMHC vs HOV Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, HOV has a market cap of 604.3M. Regarding current trading prices, TMHC is priced at $63.24, while HOV trades at $117.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas HOV's P/E ratio is 18.12. In terms of profitability, TMHC's ROE is +0.11%, compared to HOV's ROE of +0.07%. Regarding short-term risk, TMHC is less volatile compared to HOV. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check HOV's competition here
TMHC vs LEGH Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, LEGH has a market cap of 509.8M. Regarding current trading prices, TMHC is priced at $63.24, while LEGH trades at $21.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas LEGH's P/E ratio is 12.30. In terms of profitability, TMHC's ROE is +0.11%, compared to LEGH's ROE of +0.08%. Regarding short-term risk, TMHC is less volatile compared to LEGH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LEGH's competition here
TMHC vs SIC Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, SIC has a market cap of 376M. Regarding current trading prices, TMHC is priced at $63.24, while SIC trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas SIC's P/E ratio is 7.11. In terms of profitability, TMHC's ROE is +0.11%, compared to SIC's ROE of -0.06%. Regarding short-term risk, TMHC is more volatile compared to SIC. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check SIC's competition here
TMHC vs UHG Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, UHG has a market cap of 69.4M. Regarding current trading prices, TMHC is priced at $63.24, while UHG trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas UHG's P/E ratio is -4.21. In terms of profitability, TMHC's ROE is +0.11%, compared to UHG's ROE of -0.23%. Regarding short-term risk, TMHC is more volatile compared to UHG. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check UHG's competition here
TMHC vs SPHL Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, SPHL has a market cap of 3.8M. Regarding current trading prices, TMHC is priced at $63.24, while SPHL trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas SPHL's P/E ratio is -2.37. In terms of profitability, TMHC's ROE is +0.11%, compared to SPHL's ROE of -0.23%. Regarding short-term risk, TMHC is less volatile compared to SPHL. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check SPHL's competition here
TMHC vs NWHM Comparison April 2026
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 5.9B. In comparison, NWHM has a market cap of 0. Regarding current trading prices, TMHC is priced at $63.24, while NWHM trades at $8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 9.42, whereas NWHM's P/E ratio is N/A. In terms of profitability, TMHC's ROE is +0.11%, compared to NWHM's ROE of -0.15%. Regarding short-term risk, TMHC is more volatile compared to NWHM. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check NWHM's competition here